|
Market Closed -
Nasdaq
00:00:00 29/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.870 USD | -1.62% |
|
-40.39% | +22.36% |
| Market Cap | 72.97M 65.47M 60.53M 54.82M 102M 6.95B 104M 724M 288M 3.64B 274M 268M 11.54B | P/E 2024 |
-5.14x | P/E 2025 | -20.8x |
|---|---|---|---|---|---|
| Enterprise Value | 71.7M 64.33M 59.48M 53.87M 101M 6.83B 102M 711M 283M 3.57B 269M 263M 11.34B | EV / Sales 2024 |
0.95x | EV / Sales 2025 | 1.31x |
| Free-Float |
57.75% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CPIX | Delayed | |
CBOE
| CPIX | Real-time |
Last Transcript: Cumberland Pharmaceuticals Inc.
| 1 day | -1.62% | ||
| 1 week | -40.39% | ||
| Current month | -37.80% | ||
| 1 month | -36.92% | ||
| 3 months | -28.49% | ||
| 6 months | +13.79% | ||
| Current year | +22.36% |
| 1 week | 4.2 |  | 8.76 |
| 1 month | 4.2 | | 8.76 |
| Current year | 2.69 | | 9.28 |
| 1 year | 1.85 | | 9.28 |
| 3 years | 1.04 | | 9.28 |
| 5 years | 1.04 | | 9.28 |
| 10 years | 0 | | 9.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 67 | 07/01/1999 |
John Hamm
DFI | Director of Finance/CFO | 70 | 17/05/2021 |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CHM | Chairman | 67 | 07/01/1999 |
Gordon Bernard
BRD | Director/Board Member | 74 | 10/09/2010 |
James Jones
BRD | Director/Board Member | 78 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/03/26 | Free | Executive/Senior Manager | 3,000 | 0.0201% | ||
| 18/03/26 | Free | Director | 5,800 | 0.0388% | ||
| 18/03/26 | Free | Director | 1,800 | 0.0120% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.62% | -40.39% | +47.58% | +139.31% | 72.97M | |
| +0.50% | +1.38% | +57.09% | +129.96% | 1,148B | |
| +0.86% | +5.14% | +45.00% | +86.15% | 652B | |
| -0.14% | +0.42% | +25.69% | +105.85% | 505B | |
| -0.05% | +1.73% | +52.74% | +67.74% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.06% | 348B | |
| +0.34% | +1.84% | +30.70% | +54.27% | 294B | |
| -0.45% | +1.19% | +2.89% | +26.08% | 264B | |
| +0.87% | +3.08% | +54.69% | +72.74% | 244B | |
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | |
| Average | -0.02% | -2.79% | +41.33% | +82.69% | 403.72B | |
| Weighted average by Cap. | +0.26% | +1.50% | +44.52% | +89.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 37.87M 33.98M 31.41M 28.45M 53.15M 3.61B 53.79M 376M 150M 1.89B 142M 139M 5.99B | 44.52M 39.94M 36.93M 33.45M 62.49M 4.24B 63.24M 442M 176M 2.22B 167M 164M 7.04B |
| Net income | -6.48M -5.81M -5.37M -4.87M -9.09M -617M -9.2M -64.26M -25.6M -323M -24.32M -23.8M -1.03B | -2.84M -2.54M -2.35M -2.13M -3.98M -270M -4.03M -28.13M -11.2M -141M -10.64M -10.42M -449M |
| Net Debt | 2.61M 2.34M 2.16M 1.96M 3.66M 248M 3.7M 25.87M 10.3M 130M 9.79M 9.58M 413M | -1.26M -1.13M -1.05M -950K -1.77M -120M -1.8M -12.54M -4.99M -63.01M -4.74M -4.64M -200M |
Employees
88
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | $4.870 | -1.62% | 141,316 |
| 27/10/26 | $4.950 | +13.79% | 542,992 |
| 26/10/26 | $4.350 | -48.76% | 501,543 |
| 23/10/26 | $8.490 | +0.12% | 44,315 |
| 22/10/26 | $8.480 | +3.79% | 39,177 |
- Stock Market
- Stocks
- CPIX Stock
Select your edition
All financial news and data tailored to specific country editions
